Skip to content

13F-HR filed by Logos Global Management LP

Logos Global Management LP filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 32 holding rows worth $545,070,000.

Accession
0001172661-22-001928
Filed
2022-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 32 entries on the cover page, a total value of $545,070,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $545,070,000 with VALUE read as thousands by filing date, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CYTOKINETICS INC23282W605COM NEW1,750,000$68,758,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM1,500,000$67,830,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock3,750,000$51,750,000thousands by filing date
DESIGN THERAPEUTICS INC25056L103COM2,797,501$39,165,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM400,000$29,984,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM300,000$29,244,000thousands by filing date
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS1,700,000$28,526,000thousands by filing date
Ventyx Biosciences Inc92332V107Common Stock2,312,680$28,284,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS350,000$27,916,000thousands by filing date
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK3,136,352$25,373,000thousands by filing date
ARCUTIS BIOTHERAPEUTICS INC03969K108COM1,000,000$21,310,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock2,900,000$19,923,000thousands by filing date
KARUNA THERAPEUTICS INC48576A100COM150,000$18,977,000thousands by filing date
DICE THERAPEUTICS INC23345J104COM985,251$15,291,000thousands by filing date
OLEMA PHARMACEUTICALS INC68062P106COM3,743,875$15,238,000thousands by filing date
CHEMOCENTRYX INC16383L106COM600,000$14,868,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK1,950,000$9,555,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM650,000$9,159,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM950,000$7,857,000thousands by filing date
CENTURY THERAPEUTICS INC15673T100COM476,559$4,003,000thousands by filing date
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS399,801$1,947,000thousands by filing date
SPRUCE BIOSCIENCES INC85209E109COM1,000,000$1,740,000thousands by filing date
Instil Bio, Inc.45783C101Common Stock369,800$1,708,000thousands by filing date
TALARIS THERAPEUTICS INC87410C104COM270,987$1,222,000thousands by filing date
EDGEWISE THERAPEUTICS INC28036F105COM150,000$1,194,000thousands by filing date
TYRA BIOSCIENCES INC90240B106COMMON STOCK166,526$1,191,000thousands by filing date
LIANBIO ADR53000N108COM394,486$852,000thousands by filing date
ATHIRA PHARMA INC04746L104COM220,000$671,000thousands by filing date
VIGIL NEUROSCIENCE INC92673K108COM205,595$530,000thousands by filing date
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock220,434$525,000thousands by filing date
NUVALENT INC COM670703107Stock33,887$460,000thousands by filing date
NUVATION BIO INC67080N119WARR66,666$19,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-22-001928this filing2022-08-15acceptance time not in the bulk data set